Conmed Corp
NYSE:CNMD
Conmed Corp
Net Income (Common)
Conmed Corp
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Conmed Corp
NYSE:CNMD
|
Net Income (Common)
$82.3m
|
CAGR 3-Years
83%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Conmed Corp's Net Income (Common)?
Net Income (Common)
82.3m
USD
Based on the financial report for Mar 31, 2024, Conmed Corp's Net Income (Common) amounts to 82.3m USD.
What is Conmed Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
9%
The average annual Net Income (Common) growth rates for Conmed Corp have been 83% over the past three years , 21% over the past five years , and 9% over the past ten years .